February 22, 2024 Experience Cardinal Health $1.15 billion notes offering The investment-grade notes are due 2029 and 2034
February 21, 2024 Experience Prime Medicine $161 million stock and pre-funded warrants offering The common stock is listed on the Nasdaq Global Market
February 14, 2024 Experience Cigna $4.5 billion senior notes offering The senior notes are due 2029, 2031, 2034 and 2054
February 13, 2024 Experience Metagenomi $93.75 million IPO The shares are listed on the Nasdaq Global Market
February 12, 2024 Experience Tenaya Therapeutics $50 million stock and pre-funded warrants offering The stock is listed on the Nasdaq Global Select Market
February 12, 2024 Experience Eli Lilly $6.5 billion notes offering The investment-grade notes are due 2027, 2029, 2034, 2054 and 2064
February 5, 2024 Experience Immunocore Holdings $402.5 million convertible notes offering The 2.5% convertible notes are due 2030
January 23, 2024 Experience Immatics $201 million follow-on offering We advised Immatics on the offering of shares
January 22, 2024 Experience IDEAYA Biosciences $350 million at-the-market offering The shares are listed on the Nasdaq Global Select Market
January 22, 2024 Experience Alector $75 million stock offering The common stock is listed on the Nasdaq Global Select Market